1 asset in Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis 1

Therapeutic assets addressing Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis 1, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Alnugranogene Aldeparvovec Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis 1	Passage Bio, Inc.	P1/2	CCC (48)